【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2014 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2014 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2014 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2014 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2014 19
2.4.1 Actavis to Acquire Allergan for USD66 Billion 19
2.4.2 Medtronic Raises USD17 Billion in Private Placement of Notes 20
2.4.3 Merck Acquires Cubist Pharma for USD9.5 Billion 20
2.4.4 Bayer Raises USD7 Billion in Public Offering Bonds 21
2.4.5 LabCorp to Acquire Covance for USD6.1 Billion 21
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 23
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2014 23
3.1.1 Top M&A Deals in Q4 2014 24
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2013 – Q4 2014 25
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2014 26
3.2.1 Top Initial Public Offerings in Q4 2014 27
3.2.2 Top Secondary Offerings in Q4 2014 28
3.2.3 Top PIPE Deals in Q4 2014 28
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2013-Q4 2014 29
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2013 – Q4 2014 29
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2014 31
3.3.1 Top Venture Financing Deals in Q4 2014 32
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 33
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 34
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2013 – Q4 2014 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2013 – Q4 2014 36
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2013 – Q4 2014 37
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2014 38
3.4.1 Top Private Equity Deals in Q4 2014 39
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2013 – Q4 2014 40
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2013 – Q4 2014 44
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 46
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2014 47
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2014 48
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2014 48
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 49
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2013 – Q4 2014 51
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2013 – Q4 2014 52
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 53
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 57
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2014 58
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2014 59
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2014 60
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2013 – Q4 2014 61
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 63
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 65
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 66
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 68
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 70
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2013 – Q4 2014 70
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2013 – Q4 2014 72
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2013 – Q4 2014 73
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2013 – Q4 2014 75
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2013 – Q4 2014 77
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2013 – Q4 2014 78
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2013 – Q4 2014 79
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 80
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2014 80
7.1.1 Oncology – Deals of the Quarter 82
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2014 84
7.2.1 Central Nervous System – Deals of the Quarter 86
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2014 88
7.3.1 Infectious Disease – Deals of the Quarter 89
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2014 92
7.4.1 Immunology – Deals of the Quarter 94
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2014 96
7.5.1 Metabolic Disorders – Deals of the Quarter 97
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2014 100
7.6.1 Cardiovascular – Deals of the Quarter 101
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2014 103
7.7.1 Gastrointestinal – Deals of the Quarter 104
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2014 106
7.8.1 Dermatology – Deals of the Quarter 107
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2014 109
7.9.1 Respiratory – Deals of the Quarter 110
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2014 113
7.10.1 Ophthalmology – Deals of the Quarter 114
8 Deal Summary by Geography 117
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2014 117
8.1.1 North America – Deals of the Quarter 119
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2014 121
8.2.1 Europe – Deals of the Quarter 122
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2014 126
8.3.1 Asia-Pacific – Deals of the Quarter 127
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2014 129
8.4.1 Rest of the World – Deals of the Quarter 130
9 Pharmaceuticals & Healthcare, Global, Top Advisors 132
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q4 2013 – Q4 2014 132
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q4 2013 – Q4 2014 134
10 Appendix 136
11 Further Information 139
11.1 Methodology 139
11.2 About GlobalData 140
11.3 Disclosure information 141
11.4 Disclaimer 141
【レポート販売概要】
■ タイトル：世界の製薬産業における事業提携、ライセンス、投資、M&A動向（2014年第4四半期版）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014
■ 発行日：2015年2月15日
■ 調査会社：GlobalData
■ 商品コード：GDPH0473QD
■ 調査対象地域：グローバル
- 包装機械の世界市場2015-2022According to Stratistics MRC, the Global Packaging Machinery Market is accounted for $31.5 billion in 2015 and is expected to reach $48.15 billion by 2022 growing at a CAGR of 6.25% from 2015 to 2022. The factors such as rising advancements in modular packaging machines, growing accessibility of packaged foods, multipacks and increasing adoption of automatic machines in multiple sectors are some o …
- 先端相変化材料(PCM)の世界市場：有機PCM、無機PCM、バイオベースPCMAdvanced PCM is a type of latent heat storage material that has the property of absorbing and releasing large amount of latent heat energy through phase transformation. Though the most common PCM is ice, its use is limited due to fixed melting temperature. Advanced PCM on the other hand is manufactured using paraffin waxes, fatty acids, and salt hydrates among others in which the melting temperatu …
- コンテンツデリバリネットワーク（CDN）の世界市場：主要ベンダー、市場現状、展望Next generation applications, content, and commerce offerings are driving the need for flexible and cost effective Content Delivery Network (CDN) solutions, which core services such as aggregation, management, and distribution of content as well as a variety of value-added functionality. The market need for CDN solutions correlates directly with the explosion of broadband networks, smart mobile ph …
- モバイルマッピングの世界市場：LBS（位置情報サービス）、ローカルサーチ、ジオロケーション、SoLoMo、GIS、空間データThe latest report from business intelligence provider visiongain offers comprehensive analysis of the global mobile mapping market. Visiongain assesses that this market will generate revenues of $30.56 billion in 2015. Now: Uber Loses $3bn Bid For Nokia HERE Maps To German Car Makers. This is an example of the business critical headline that you need to know about - and more importantly, you need …
- 世界の眼疾患治療薬分野における主要な製薬企業分析New study shows you commercial prospects for leading ophthalmic drug companies What does the future hold for top companies in the pharma ophthalmic industry? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there. Our 242-page report provides 185 tables, charts, and graphs. Discover the most lucrative areas in the industry and …
- アクアリウム用品の世界市場2016-2020About Fish Keeping Fish keeping is among the most popular of hobbies among millions of enthusiasts around the world. The US is the single largest importer of ornamental fish in the world. More than 2,500 marine fish species and 750 invertebrates have been imported into the US since 2000 to meet the demand of hobbyists in the country. Technavio’s analysts forecast the global aquarium accessories ma …
- 世界の電気制御・配電機器市場（～2019）This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for electricity control and distribution equipment in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other p …
- 世界の熱媒体流体市場動向及び予測（～2019）Heat transfer fluids have found a wide acceptance in various industries, because of their distinguished properties. Based on application areas, the market of heat transfer fluids can broadly be segmented into oil & gas, concentrating solar power, chemical industry, manufacturing processes, pharmaceuticals, bio-diesel production, and others. Though oil & gas and concentrating solar power markets ar …
- メタクリル酸ヒドロキシプロピルの世界市場Hydroxypropyl Methacrylate (CAS 27813-02-1) Market Research Report 2013 presents comprehensive data on hydroxypropyl methacrylate markets globally and regionally (Europe, Asia, North America etc.) The Hydroxypropyl Methacrylate (CAS 27813-02-1) Market Research Report 2013 includes hydroxypropyl methacrylate description, covers its application areas and related patterns. It overviews hydroxypropyl …
- Griseofulvin (Dermatophytic Onychomycosis)：市場予測と分析（～2022）Griseofulvin (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Griseofulvin (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nai …
- 月経カップの世界市場予測IntroductionA menstrual cup is a revolutionary product in the women hygiene market introduced as an alternative to sanitary napkins or tampons to be used during menstruation. It is eco-friendly and does not cause toxic syndrome or vaginal dryness as it is made from 100% medical grade silicone. The menstrual cups market can be driven by increasing women population in developed and developing countr …
- 自動車用診断スキャンツールの世界市場予測：診断装置、診断ソフトウェア、修理・診断データThe automotive diagnostic scan tools market, in terms of value, is projected to grow at a CAGR of 5.9% from 2016 to 2021. The market is estimated to be USD 5.45 Billion in 2016, and is projected to reach 7.24 Billion by 2021. The key drivers of this market are increasing consumer preference for technologically advanced automobiles and rise in demand for automotive workshops. Stringency in emission …
- Derma Sciences, Inc.：市場シェア分析Derma Sciences, Inc. Market Share Analysis Summary GlobalData’s new report, “Derma Sciences, Inc. Market Share Analysis” provides in-depth information on Derma Sciences, Inc.’s market position in the different medical equipment markets it operates in. The report provides Derma Sciences, Inc. market share information in three key market categories – Advanced Wound Management, Traditional Wound Mana …
- 医療用真空システムの世界市場予測（～2024年）“The medical vacuum systems market is projected to grow at a CAGR of 6.3%.”The global medical vacuum systems market is projected to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2018, at a CAGR of 6.3%. The adoption of medical vacuum systems is growing across major healthcare markets, mainly due to technological advancements, stringent regulatory frameworks mandating the use of vacuum syst …
- 世界の変圧器油市場Transformer oil is a dielectric fluid mainly used in oil filled electrical transformers as an insulating and cooling medium. It is usually obtained by fractional distillation and subsequent processing of crude oil. The primary purpose of transformer oil is to insulate and cool the transformer windings and core. These also preserve the core and winding as these are fully immersed in the oil and pre …
